Home / Insulin Lispro / United States
US ATC A10AB04 · updated 2 Nov 2026
Insulin Lispro shortage in United States
Is there an Insulin Lispro shortage in United States?
Yes. As of 2 Nov 2026, 2 Insulin Lispro products are reported short in United States, the first since 1 Sep 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Norway. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Humalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05) discontinuation | Eli Lilly and Co. | 1 Sep 2026 | not given | Not stated |
| US | Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05) discontinuation | Eli Lilly and Co. | 1 Sep 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).